Human PHKA1 knockout HEK-293T cell lysate
Be the first to review this product! Submit a review
|
(0 Publication)
- WB
Lab
Western blot - Human PHKA1 knockout HEK-293T cell lysate (AB258111)
Lanes 1 - 2:
Western blot - Anti-PHKA1 antibody [EPR12118] - BSA and Azide free (<a href='/en-us/products/primary-antibodies/phka1-antibody-epr12118-bsa-and-azide-free-ab249913'>ab249913</a>) at 1/1000 dilution
Lanes 1 - 2:
Western blot - Anti-PHKA1 antibody [EPR12118] (<a href='/en-us/products/primary-antibodies/phka1-antibody-epr12118-ab176338'>ab176338</a>) at 1/1000 dilution
Lane 1:
Wild-type HEK-293T cell lysate at 20 µg
Lane 2:
PHKA1 knockout HEK-293T cell lysate at 20 µg
Lane 2:
Western blot - Human PHKA1 knockout HEK-293T cell line (<a href='/en-us/products/cell-lines/human-phka1-knockout-hek-293t-cell-line-ab267337'>ab267337</a>)
Lane 2:
Western blot - Human PHKA1 knockout HEK-293T cell lysate (ab258111)
Secondary
All lanes:
Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution
Observed band size: 130 kDa
false
- Sanger seq
Unknown
Sanger Sequencing - Human PHKA1 knockout HEK-293T cell lysate (AB258111)
Homozygous : 2 bp deletion in exon14
Product details
Knockout cell lysate achieved by CRISPR/Cas9.
REACH authorisation
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.
Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.
User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.
This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.
What's included?
Properties and storage information
Gene name
Gene editing type
Gene editing method
Knockout validation
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
Glycogen metabolism involves PHKA1 as part of the phosphorylase kinase complex. This complex exists in the muscle and liver and includes alpha beta gamma and delta subunits. PHKA1 binds together with these subunits to form a large complex helping to regulate the activity state of the enzyme. The regulation of glycogen phosphorylase is important for maintaining energy supply in cells particularly during physical activity.
Pathways
The activity of PHKA1 impacts glycogenolysis which is a significant metabolic pathway responsible for breaking down glycogen into glucose-1-phosphate. This pathway involves other proteins like glycogen phosphorylase and phosphoprotein phosphatase 1. PHKA1 has interactions within the cascade that ensures proper glycogen breakdown especially during conditions requiring increased energy output.
Quality control
STR analysis
CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX
Cell culture
Biosafety level
EU: 2 US: 2
Adherent/suspension
Adherent
Gender
Female
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com